Research Use Only Platform
Age & Research Verification
This platform contains information about research-grade peptide compounds for qualified scientific investigators. Please confirm the following before proceeding.
FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN USE · NOT FDA-EVALUATED
cynerabiolabs.com
All Compounds
Metabolic
Recovery
Catalog & Pricing
Order / Contact
Advanced Research Platform · 2026

Peptide Research
Reference Catalog

Educational reference platform for laboratory research compounds — with full mechanism profiles, literature citations, and analytical documentation.

20+
Research Compounds
COA
Batch Documentation
U.S.
Based Fulfillment
FOR LABORATORY & SCIENTIFIC RESEARCH USE ONLY. All information on this platform is provided for educational and research reference purposes. Compounds are intended solely for in-vitro laboratory research by qualified personnel. Not for human consumption, medical treatment, or diagnostic use. Not evaluated or approved by the FDA. No medical claims are made or implied. Reference pricing shown is informational only.
⚡ Important Research Distinction — Full-Length Tβ4 (43aa) vs. TB-500 Fragment (7aa)
This catalog references True Full-Length Thymosin Beta-4 (43aa, CAS 77591-33-4) — the complete naturally occurring protein, not the shortened fragment commonly sold as "TB-500."
TB-500 Fragment (7aa)

Synthetic LKKTETQ heptapeptide — a single actin-binding subdomain. Widely sold at lower cost. A partial derivative, not the complete molecule.

Full-Length Tβ4 (43aa) — This Product

Complete naturally occurring protein (CAS 77591-33-4). Encompasses ALL biological domains including nuclear translocation, gene regulation, cardiac progenitor activation, and actin dynamics.

The full-length 43aa version is generally considered the more biologically complete form for research. This is an educational distinction — not a claim of proven medical superiority.
Research Compounds
20 compounds
Research Grade & Quality
Analytical documentation standards
🔬
HPLC Purity Verified
≥99% purity confirmation
High-Performance Liquid Chromatography separates and quantifies each compound to confirm purity at ≥99% prior to release.
⚗️
LC-MS Identity Confirmed
Identity verification via LC-MS
Liquid Chromatography–Mass Spectrometry confirms molecular identity by verifying mass and sequence integrity of each compound.
📄
Documentation Support
Analytical reports available on request
Analytical documentation including test reports is available upon request. Contact us directly for documentation specific to your research needs.
🧊
Lyophilized Format
Freeze-dried peptide format
Freeze-drying preserves peptide integrity and extends stability during storage and transit without compromising structural composition.
⚖️
Fill Weight Verified
Verified peptide content per vial
Each vial is verified by fill weight to confirm actual peptide content aligns with the labeled quantity.
Reference Pricing · Educational & Informational

Research Compound Reference Catalog

Pricing shown is informational and reflects research documentation, compound preparation, and analytical verification. All compounds are for laboratory and scientific research use only. Pinealon (EDR) — cognitive and longevity research.

Reference pricing reflects research information access, compound documentation, analytical COA, and preparation costs. Purchases are made by qualified researchers for in-vitro laboratory research purposes only. Not for human consumption. No medical claims are made or implied.
Core Research Compounds
Recovery · Immune · Cellular
Metabolic & Performance
GH Axis · Body Composition · Weight Management
Premium & Specialty
Longevity · Mitochondrial · Cognitive · Neuropeptide
Research Blends
Multi-compound formulations
Supplemental Compounds
Cellular cofactors & support
Nasal Spray Formulations
Intranasal research formulations · Research Use Only
Precision-formulated intranasal research compounds for laboratory investigation of mucosal delivery and CNS pathway research.
📋
FDA Advisory Committee Update — July 23–24, 2026
Educational Information Only  ·  Not FDA Approval  ·  Not Authorization to Compound
FDA Pharmacy Compounding Advisory Committee (PCAC) — July 23–24, 2026
The FDA Pharmacy Compounding Advisory Committee (PCAC) met on July 23–24, 2026 to consider certain bulk drug substances in connection with the 503A compounding bulks list. The substances and associated clinical conditions considered at that meeting are listed below. Advisory committee recommendations are non-binding. They do not constitute FDA approval, do not authorize compounding, and do not represent final agency action. No determination by the committee should be read as evidence that any Cynera Labs research material is approved, safe for human use, or effective for any indication. Any final FDA action on these substances would occur through a separate official process.
Conditions Reviewed by the Committee
Compound Conditions Reviewed by Committee Status
July 23, 2026
BPC-157 Ulcerative colitis Non-binding recommendation
KPV Wound healing; inflammatory conditions Non-binding recommendation
TB-500 (Thymosin Beta-4) Wound healing Non-binding recommendation
MOTS-c Obesity; osteoporosis Non-binding recommendation
July 24, 2026
Emideltide / DSIP Opioid withdrawal; chronic insomnia; narcolepsy Non-binding recommendation
Semax Cerebral ischemia; migraine; trigeminal neuralgia Non-binding recommendation
Epitalon / Epithalon Insomnia Non-binding recommendation
⚠ Important Notice
This section summarizes topics discussed at the FDA Pharmacy Compounding Advisory Committee (PCAC) meeting held July 23–24, 2026. Advisory committee activity does not constitute FDA approval, does not authorize compounding, and is not evidence of safety or effectiveness for human use. The committee's recommendations are non-binding on FDA. Final determinations regarding the 503A Bulks List occur through a separate official FDA rulemaking or administrative process.

All Cynera Labs materials are Research Use Only (RUO) — not FDA-approved drugs, not intended for human use, not intended to diagnose, treat, cure, or prevent any disease. Any subsequent official FDA action regarding these substances should be verified through FDA.gov.
Shipping
Flat Rate Shipping
$12

A flat $12 shipping charge applies to all orders.

All pricing is reference/informational. Contact us to confirm availability and current documentation pricing.

Ready to Order? Questions?

Need product information? Looking for a product that isn't listed? Please text or email us regarding availability, pricing, product information, or general consultation. Most in-stock orders ship the same or next business day.

1

Contact Us

Text or email us with your compounds of interest, your name, and shipping address. We respond promptly via call, text, or email.

2

Confirm & Document

We confirm availability, provide COA documentation, and discuss your inquiry. Most in-stock orders ship the same or next business day.

3

Choose Payment

We Accept:

  • Venmo
  • PayPal
  • Zelle
  • Cryptocurrency

Payment Reason: Consultation

Founder
Jeff Extor
Cynera Labs
Phone / Text
Research inquiries & availability
Email
Research inquiries & documentation
Research Use Disclaimer: All compounds are provided for laboratory and scientific research use only. Not for human consumption, veterinary use, or medical treatment. Not FDA-evaluated or approved. Reference pricing reflects research documentation, compound preparation, and analytical verification costs. The buyer assumes full legal responsibility for compliance with all applicable laws. Cynera Labs assumes no liability for improper use.
Contact & Support

Questions? We're here.

For additional information, analytical questions, sourcing inquiries, documentation support, or payment options, please contact us directly by phone, text, or email.

📞
Phone / Text
484-471-9527
✉️
Email
team@cynerabiolabs.com
👤
Founder
Jeff Extor · Cynera Labs